Skip to main content
SpringerLink
Log in
Book cover

Pathology of the Ovary, Fallopian Tube and Peritoneum pp 259–271Cite as

Clear Cell Carcinoma of the Ovary

  • Chapter
  • First Online:

Part of the book series: Essentials of Diagnostic Gynecological Pathology ((EDGP))

Abstract

There is little known about the treatment of gynecological clear cell carcinomas, but there is a rapidly accumulating appreciation that they are a more diverse group of tumors than was previously known. The combination of conventional histological analysis of this variable group together with other biological parameters has given rise to an individualized approach to devising new treatments. However, we still rely on the recognition of their histopathological appearances which are described in this chapter.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Serov SF, Scully RE, Sobin LH. International histologic classification of tumours. No. 9 histologic typing of ovarian tumours. Geneva: World Health Organization; 1973. p. 1–7.

    Google Scholar 

  2. Tsuchiya A, Sakamoto M, Yasuda J, et al. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol. 2003;163(6):2503–12.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Gutgemann I, Lehman NL, Jackson PK, Longacre TA. Emi 1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma. Mod Pathol. 2008;21(4):445–54.

    Article  PubMed  Google Scholar 

  4. Sugiyama T, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histological type with poor prognosis and resistance to platinum-based chemotherapy. Cancer. 2000;88(11):2584–9.

    Article  PubMed  CAS  Google Scholar 

  5. Ho CM, et al. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum based chemotherapy in pure-type advanced disease. Gynecol Oncol. 2004;94(1):197–203.

    Article  PubMed  CAS  Google Scholar 

  6. Goff BA, et al. Clear cell carcinoma of the ovary: a distinct histologic type with a poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol. 1996;60(3):412–7.

    Article  PubMed  CAS  Google Scholar 

  7. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have a poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol. 2008;109(3):370–6.

    Article  PubMed  Google Scholar 

  8. Ushijimi K. Current status of gynecologic cancer in Japan. J Gynecol Oncol. 2009;20(2):67–71.

    Article  Google Scholar 

  9. Lim MC, Lee DO, Kang S, Seo SS, Lee BY, Park SY. Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis. Gynecol Endocrinol. 2009;25(7):435–40.

    Article  PubMed  Google Scholar 

  10. Jenison EL, et al. Clear cell adenocarcinomas of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol. 1989;32(1):65–71.

    Article  PubMed  CAS  Google Scholar 

  11. Kobayashi H, et al. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study Shizouka, Japan. Int J Gynecol Cancer. 2007;17(1):37–43.

    Article  PubMed  CAS  Google Scholar 

  12. Komiyama S, et al. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathological evaluation. Gynecol Oncol. 1999;72(3):342–6.

    Article  PubMed  CAS  Google Scholar 

  13. Erzen M, et al. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case control study. Gynecol Oncol. 2001;83(1):100–8.

    Article  PubMed  CAS  Google Scholar 

  14. Orezzoli JP, et al. Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol. 2008;110:336–44.

    Article  PubMed  CAS  Google Scholar 

  15. Munksgaard PS, Blaaker J. The association between endometriosis and gynecological tumours and breast cancer: a review of epidemiological data. Gynecol Oncol. 2011;123(1):157–63.

    Article  PubMed  Google Scholar 

  16. O’Brien ME, et al. Clear cell epithelial ovarian cancer (mesonephroid): a bad prognosis only in early stages. Gynecol Oncol. 1993;49:250–4.

    Article  PubMed  Google Scholar 

  17. Han G, et al. Mixed epithelial carcinomas with clear cell and serous components are variants of high grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases. Am J Surg Pathol. 2008;32(7):955–64.

    Article  PubMed  Google Scholar 

  18. Yamamoto S, et al. Clear cell adenofibroma can be a clonal precursor for clear cell adenocarcinoma of the ovary: a possible alternative ovarian carcinogenic pathway. J Pathol. 2008;216(1):103–10.

    PubMed  CAS  Google Scholar 

  19. Kato N, et al. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumours and endometriosis of the ovary. Mod Pathol. 2006;19(1):83–9.

    Article  PubMed  CAS  Google Scholar 

  20. Higashiguchi A, et al. Specific expression of hepatocyte nuclear factor-1beta in ovarian clear cell carcinoma and its application to cytologic diagnosis. Cancer Sci. 2007;98(3):387–91.

    Article  PubMed  CAS  Google Scholar 

  21. Kobel M, et al. A panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. Am J Surg Pathol. 2009;33(1):14–21.

    Article  PubMed  Google Scholar 

  22. DeLair D, et al. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol. 2011;35(1):36–44.

    Article  PubMed  Google Scholar 

  23. Shimizu M, et al. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian carcinomas. Cancer. 1999;85(3):669–77.

    Article  PubMed  CAS  Google Scholar 

  24. Sato N, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumour suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 2000;60(24):7052–6.

    PubMed  CAS  Google Scholar 

  25. Anglesio MC et al. Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, 24 June 2010.

    Google Scholar 

  26. del Carmen MG, Birrer M, Schorge JO. Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol. 2012;126(3):481–90.

    Article  PubMed  Google Scholar 

  27. Veras EMD, et al. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumours that differ in their pathogenesis and behaviour: a clinicopathologic analysis of 122 cases. Am J Surg Pathol. 2009;33(6):844–53.

    Article  PubMed  Google Scholar 

  28. Yamamoto S, et al. Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics. Am J Surg Pathol. 2007;31(7):999–1006.

    Article  PubMed  Google Scholar 

  29. Lee YY, et al. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol. 2011;122(3):541–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Southern General Hospital, 1345 Govan Road, Glasgow, G51 4TF, Scotland, UK

    David W. M. Millan BSC, MB, CHB, FRCPath

Authors
  1. David W. M. Millan BSC, MB, CHB, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David W. M. Millan BSC, MB, CHB, FRCPath .

Editor information

Editors and Affiliations

  1. Department of Histopathology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

    Nafisa Wilkinson

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Millan, D.W.M. (2014). Clear Cell Carcinoma of the Ovary. In: Wilkinson, N. (eds) Pathology of the Ovary, Fallopian Tube and Peritoneum. Essentials of Diagnostic Gynecological Pathology. Springer, London. https://doi.org/10.1007/978-1-4471-2942-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2942-4_12

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2941-7

  • Online ISBN: 978-1-4471-2942-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation